| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention refers to an intermediate antianginal drug containing nitroglycerine, glucose, stearic acid and/or calcium or magnesium stearate, ethyl cellulose or microcrystalline cellulose with the nitroglycerine-glucose relation being (2-3):1 in the following proportions, wt %: nitroglycerine 5-15, glucose 58-86, starch 5-15, stearic acid and/or calcium or magnesium stearate 2-7, ethyl cellulose or microcrystalline cellulose 2-5. ^ EFFECT: invention provides higher stability of said intermediate drug, and uniform nitroglycerine distribution in the bulk compound. ^ 1 tbl |
